chapter seven
Publications Angalakuditi M, Seifert RF, Hayes RP, O’ Leary MP, Viktrup L. Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies. Health Qual Life Outcomes 2010 Nov 12; 8:131. doi: 10.1186 / 1477-7525-8-131.
Li NC, Chen S, Yang XH, Du LD, Wang JY, Na YQ; Beijing Tamsulosin Study Group- Efficacy of low-dose tamsulosin in Chinese patients with symptomatic benign prostatic hyperplasia Clin Drug Investig 2003; 23( 12): 781-7.
Upadhyay L, Tripathi K, Kulkarni KS. A study of prostane in the treatment of benign prostatic hyperplasia- Phytother Res. 2001 Aug; 15( 5): 411-5.
Gaynor ML. Isoflavones and the prevention and treatment of prostate disease: is there a role? Cleve Clin J Med. 2003 Mar; 70( 3): 203-4, 206, 208-9 passim. Review.
Kurashige S, Akuzawa Y, Endo F. Effects of astragali radix extract on carcinogenesis, cytokine production, and cytotoxicity in mice treated with a carcinogen, N-butyl-N’-butanolnitrosoamine. Cancer Invest. 1999; 17( 1): 30-5.
Lin J, Dong HF, Oppenheim JJ, Howard OM. Effects of astragali radix on the growth of different cancer cell lines. World J Gastroenterol 2003 Apr; 9( 4): 670-3.
Messina M, Redmond G. Effects of soy protein and soybean isoflavones on thyroid function in healthy adults and hypothyroid patients: a review of the relevant literature. Thyroid. 2006 Mar; 16( 3): 249-58. Review.
Safety, efficacy and impact on Patients’ quality of life of a long-term treatment with the alpha( 1) blocker alfuzosin in symptomatic patients with BPH- The Italian Alfuzosin Co-Operative Group Eur Urol. 2000 Jun; 37( 6): 680-6.
46